Purple Biotech Ltd. (PPBT)
1.75
+0.10
(+6.06%)
USD |
NASDAQ |
Aug 26, 14:15
Purple Biotech Total Liabilities (Quarterly) : 1.953M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.953M |
| March 31, 2026 | 4.753M |
| December 31, 2025 | 7.913M |
| September 30, 2025 | 6.246M |
| June 30, 2025 | 2.329M |
| March 31, 2025 | 2.898M |
| December 31, 2024 | 4.127M |
| September 30, 2024 | 5.638M |
| June 30, 2024 | 6.688M |
| March 31, 2024 | 8.772M |
| December 31, 2023 | 10.00M |
| September 30, 2023 | 6.553M |
| June 30, 2023 | 5.254M |
| March 31, 2023 | 6.036M |
| December 31, 2022 | 7.524M |
| September 30, 2022 | 6.434M |
| June 30, 2022 | 6.085M |
| March 31, 2022 | 7.975M |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 1.383M |
| September 30, 2015 | 1.409M |
| June 30, 2015 | 0.877M |
| March 31, 2015 | 0.643M |
| December 31, 2014 | 0.9152M |
| September 30, 2014 | 1.094M |
| June 30, 2014 | 0.797M |
| March 31, 2014 | 0.998M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Teva Pharmaceutical Industries Ltd. | 32.10B |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 27.45M |
| Sol-Gel Technologies Ltd. | 5.66M |
| PolyPid Ltd. | 9.846M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.17M |
| Shareholders Equity (Quarterly) | 12.27M |
| Debt to Equity Ratio | 0.0109 |
| Current Ratio | 3.696 |
| Net Debt Paydown Yield | 0.02% |